Verification of a proteomic biomarker panel to diagnose minor stroke and transient ischaemic attack: phase 1 of SpecTRA, a large scale translational study

References

• Addona, T.A., et al., 2011. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. Nature biotechnology, 29 (7), 635–643.
   PubMed Web of Science ®Google Scholar
• Aihara, K., et al., 2009. Heparin cofactor II is an independent protective factor against peripheral arterial disease in elderly subjects with cardiovascular risk factors. Journal of atherosclerosis and thrombosis, 16 (2), 127–134.
   PubMed Web of Science ®Google Scholar
• Aihara, K., et al., 2004. Heparin cofactor II is a novel protective factor against carotid atherosclerosis in elderly individuals. Circulation, 109 (22), 2761–2765.
   PubMed Web of Science ®Google Scholar
• Albers, G.W., et al., 2002. Transient ischemic attack-proposal for a new definition. The New England journal of medicine, 347 (21), 1713–1716.
   PubMed Web of Science ®Google Scholar
• Anderson, N.L., et al., 2004. Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA). Journal of proteome research, 3 (2), 235–244.
   PubMed Web of Science ®Google Scholar
• Benjamini, Y. and Hochberg, Y., 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B, statistical methodology, 57 (1), 289–300.
   Web of Science ®Google Scholar
• Bhakuni, T., et al., 2016. Role of heparin and non heparin binding serpins in coagulation and angiogenesis: a complex interplay. Archives of biochemistry and biophysics, 604, 128–142.
   PubMed Web of Science ®Google Scholar
• Biasiutti, F.D., et al., 2003. Hemostatic risk factors in ischemic stroke. Thrombosis and haemostasis, 90 (6), 1094–1099.
   PubMed Web of Science ®Google Scholar
• Birenbaum, D., Bancroft, L.W., and Felsberg, G.J., 2011. Imaging in acute stroke. The Western journal of emergency medicine, 12 (1), 67–76.
   PubMedGoogle Scholar
• Bongers, T.N., et al., 2006. High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability. Stroke. 37 (11), 2672–2677.
   PubMed Web of Science ®Google Scholar
• Borchers, C.H. and Parker, C.E., 2010. Improving the biomarker pipeline. Clinical chemistry, 56 (12), 1786–1788.
   PubMed Web of Science ®Google Scholar
• Bourquard, N., et al., 2008. The role of PON2 and PON3 in atherosclerosis and related traits. In: B. Mackness, et al., eds. The paraoxonases: their role in disease development and xenobiotic metabolism. Dordrecht, NLD: Springer Netherlands, 103–128.
   Google Scholar
• Brott, T., et al., 1989. Measurements of acute cerebral infarction: a clinical examination scale. Stroke, 20 (7), 864–870.
   PubMed Web of Science ®Google Scholar
• Brouns, R. and Deyn, P.D., 2009. The complexity of neurobiological processes in acute ischemic stroke. Clinical neurology and neurosurgery, 111 (6), 483–495.
   PubMed Web of Science ®Google Scholar
• Bustamante, A., et al., 2016. Factor seven activating protease (FSAP) predicts response to intravenous thrombolysis in acute ischemic stroke. International journal of stroke, 11 (6), 646–655.
   PubMed Web of Science ®Google Scholar
• Bustamante, A., et al., 2017. Blood biomarkers for the early diagnosis of stroke: the stroke-chip study. Stroke, 48 (9), 2419–2425.
   PubMed Web of Science ®Google Scholar
• Carroll, V.A., et al., 1997. Plasma protein C inhibitor is elevated in survivors of myocardial infarction. Arteriosclerosis, thrombosis, and vascular biology, 17 (1), 114–118.
   PubMed Web of Science ®Google Scholar
• Casaubon, L.K., et al., 2015. Canadian stroke best practice recommendations: hyperacute stroke care guidelines, update 2015. International journal of stroke, 10 (6), 924–940.
   PubMed Web of Science ®Google Scholar
• Conway, E.M., et al., 2003. Survivin-dependent angiogenesis in ischemic brain. American journal of pathology, 163 (3), 935–946.
   PubMed Web of Science ®Google Scholar
• Coutts, S.B., et al., 2014. Canadian stroke best practice recommendations: secondary prevention of stroke guidelines, update 2014. International journal of stroke, 10 (3), 282–291.
   PubMed Web of Science ®Google Scholar
• Crisostomo, R.A., Garcia, M.M., and Tong, D.C., 2003. Detection of diffusion-weighted MRI abnormalities in patients with transient ischemic attack: correlation with clinical characteristics. Stroke, 34 (4), 932–937.
   PubMed Web of Science ®Google Scholar
• Croll, S.D. and Wiegand, S.J., 2001. Vascular growth factors in cerebral ischemia. Molecular neurobiology, 23 (2–3), 121–136.
   PubMed Web of Science ®Google Scholar
• Easton, J.D., et al., 2009. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals. Stroke, 40 (6), 2276–2293.
   PubMed Web of Science ®Google Scholar
• Efron, B. and Gong, G., 1983. A leisurely look at the bootstrap, the jackknife, and cross-validation. The American statistician, 37 (1), 36–48.
   Web of Science ®Google Scholar
• Efstathiou, S.P., et al., 2005. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke, 36 (9), 1915–1919.
   PubMed Web of Science ®Google Scholar
• Faller, D.V., 1999. Endothelial cell responses to hypoxic stress. Clinical and experimental pharmacology and physiology, 26 (1), 74–84.
   PubMed Web of Science ®Google Scholar
• Fassbender, K., et al., 1997. Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. Journal of neurological sciences, 148 (1), 101–105.
   PubMed Web of Science ®Google Scholar
• Ferro, J., et al., 1996. Diagnosis of transient ischemic attack by the nonneurologist: a validation study. Stroke, 27 (12), 2225–2229.
   PubMed Web of Science ®Google Scholar
• Ferro, J.M., et al., 1991. Investigation into the causes of delayed diagnosis of subarachnoid hemorrhage. Cerebrovascular diseases, 1 (3), 160–164.
   Web of Science ®Google Scholar
• Fonseca, A.C. and Canhão, P., 2010. Diagnostic difficulties in the classification of transient neurological attacks. European journal of neurology, 18 (4), 644–648.
   PubMed Web of Science ®Google Scholar
• Friedman, J.H., Hastie, T., and Tibshirani, R., 2010. Regularization paths for generalized linear models via coordinate descent. Journal of statistical software, 33 (1), 1–22.
   PubMed Web of Science ®Google Scholar
• Gissel, M., et al., 2010. Plasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular events. Thrombosis research, 126 (4), 262–269.
   PubMed Web of Science ®Google Scholar
• Hanson, E., et al., 2012. Plasma factor VII-activating protease antigen levels and activity are increased in ischemic stroke. Journal of thrombosis and haemostasis, 10 (5), 848–856.
   PubMed Web of Science ®Google Scholar
• Harrell, F.E. Jr. 2016. rms: regression modeling strategies. Available from: https://CRAN.R-project.org/package=rms.
   Google Scholar
• Harrell, F.E. Jr. and Dupont, C., 2016. Hmisc: Harrell miscellaneous. Available from: https://CRAN.R-project.org/package=Hmisc.
   Google Scholar
• Hasan, N., et al., 2012. Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review. British journal of clinical pharmacology, 74 (2), 230–240.
   PubMed Web of Science ®Google Scholar
• Haught, W.H., et al., 1996. Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease. American heart journal, 132 (1), 1–8.
   PubMed Web of Science ®Google Scholar
• Hernández-Romero, D., et al., 2012. The prognostic role of the adiponectin levels in atrial fibrillation. European journal of clinical investigation, 43 (2), 168–173.
   PubMed Web of Science ®Google Scholar
• Hoppe, B., et al., 2005. Marburg I polymorphism of factor VII–activating protease is associated with idiopathic venous thromboembolism. Blood, 105 (4), 1549–1551.
   PubMed Web of Science ®Google Scholar
• Huisman, T.A.G.M., 2005. Intracranial hemorrhage: ultrasound, CT and MRI findings. European radiology, 15 (3), 434–440.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine. 2010. Evaluation of biomarkers and surrogate endpoints in chronic disease. Washington, DC: The National Academies Press.
   Google Scholar
• Ireland, H., et al., 2004. The factor VII activating protease G511E (Marburg) variant and cardiovascular risk. Thrombosis and haemostasis, 92 (5), 986–992.
   PubMed Web of Science ®Google Scholar
• Jiang, J., et al., 2007. Development of an immuno tandem mass spectrometry (iMALDI) assay for EGFR diagnosis. Proteomics – clinical applications, 1 (12), 1651–1659.
   PubMed Web of Science ®Google Scholar
• Johnsen, S.P., et al., 2005. Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. The journal of clinical endocrinology & metabolism, 90 (11), 5937–5941.
   PubMed Web of Science ®Google Scholar
• Johnston, S.C., et al., 2007. Validation and refinement of scores to predict very early stroke after transient ischaemic attack. The Lancet, 369 (9558), 283–292.
   PubMed Web of Science ®Google Scholar
• Kaplan, R.C., et al., 2007. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. The journal of clinical endocrinology & metabolism, 92 (4), 1319–1325.
   PubMed Web of Science ®Google Scholar
• Kidwell, C.S., et al., 1999. Diffusion MRI in patients with transient ischemic attacks. Stroke, 30 (6), 1174–1180.
   PubMed Web of Science ®Google Scholar
• Kölbel, T., et al., 2006. Activated protein C-protein C inhibitor complex: a new biological marker for aortic aneurysms. Journal of vascular surgery, 43 (5), 935–939.
   PubMed Web of Science ®Google Scholar
• Kraft, P., et al., 2014. Von Willebrand factor regulation in patients with acute and chronic cerebrovascular disease: a pilot, case-control study. PLoS One, 9 (6), e99851.
   PubMed Web of Science ®Google Scholar
• Laskowitz, D.T., et al., 2009. Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the biomarker rapid assessment in ischemic injury (BRAIN) study. Stroke, 40, 77–85.
   PubMed Web of Science ®Google Scholar
• Lennmyr, F., et al., 1998. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. Journal of neuropathology and experimental neurology, 57 (9), 874–882.
   PubMed Web of Science ®Google Scholar
• Linn, F., et al., 1994. Prospective study of sentinel headache in aneurysmal subarachnoid haemorrhage. The Lancet, 344 (8922), 590–593.
   PubMed Web of Science ®Google Scholar
• Lip, G. and Blann, A., 1997. Von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovascular research, 34 (2), 255–265.
   PubMed Web of Science ®Google Scholar
• Lip, G.Y., et al., 2006. Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation. Stroke, 37 (9), 2294–2300.
   PubMed Web of Science ®Google Scholar
• Luo, G.P., et al., 2012. Von Willebrand factor: more than a regulator of hemostasis and thrombosis. Acta haematologica, 128 (3), 158–169.
   PubMed Web of Science ®Google Scholar
• Macheret, F., et al., 2015. Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults. Heart, 101 (17), 1368–1374.
   PubMed Web of Science ®Google Scholar
• Maechler, M., et al., 2016. robustbase: basic robust statistics. Available from: http://CRAN.R-project.org/package=robustbase.
   Google Scholar
• Makawita, S. and Diamandis, E.P., 2009. The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification. Clinical chemistry, 56 (2), 212–222.
   PubMed Web of Science ®Google Scholar
• Marchi, N., et al., 2004. Peripheral markers of blood–brain barrier damage. Clinica Chimica Acta, 342 (1–2), 1–12.
   PubMed Web of Science ®Google Scholar
• Marousi, S., et al., 2010. Serum adiponectin acutely after an ischemic stroke: implications for a long-lasting, suppressed anti-inflammatory role. Acta neurologica scandinavica, 121 (4), 277–284.
   PubMed Web of Science ®Google Scholar
• Marsillach, J., et al., 2015. Paraoxonase-3 is depleted from the high-density lipoproteins of autoimmune disease patients with subclinical atherosclerosis. Journal of proteome research, 14 (5), 2046–2054.
   PubMed Web of Science ®Google Scholar
• McVey, J.H., 2012. Factor seven-activating protease: does it do what it says on the tin? Journal of thrombosis and haemostasis, 10 (5), 857–858.
   PubMed Web of Science ®Google Scholar
• Meijers, J.C.M., et al., 2002. Protein C inhibitor (plasminogen activator inhibitor-3) and the risk of venous thrombosis. British journal of haematology, 118 (2), 604–609.
   PubMed Web of Science ®Google Scholar
• Menih, M., Križmarić, M., and Fabjan, T.H., 2017. Clinical role of von Willebrand factor in acute ischemic stroke. Wiener klinische wochenschrift, 129 (13–14), 491–496.
   PubMed Web of Science ®Google Scholar
• Montaner, J., et al., 2010. A panel of biomarkers including caspase-3 and D-dimer may differentiate acute stroke from stroke-mimicking conditions in the emergency department. Journal of internal medicine, 270 (2), 166–174.
   PubMed Web of Science ®Google Scholar
• Morgenstern, L., et al., 1998. Worst headache and subarachnoid hemorrhage: prospective, modern computed tomography and spinal fluid analysis. Annals of emergency medicine, 32 (3), 297–304.
   PubMed Web of Science ®Google Scholar
• Ng, C.J., et al., 2005. The paraoxonase gene family and atherosclerosis. Free radical biology and medicine, 38 (2), 153–163.
   PubMed Web of Science ®Google Scholar
• NINDS. 2003. Stroke scales and related information. Bethesda, MD: National Institute of Neurological Disorders; Stroke. Available from: https://www.ninds.nih.gov/Stroke-Scales-and-Related-Information.
   Google Scholar
• Ong, S.E. and Mann, M., 2005. Mass spectrometry-based proteomics turns quantitative. Nature chemical biology, 1 (5), 252–262.
   PubMed Web of Science ®Google Scholar
• Parahuleva, M.S., et al., 2008. Factor seven activating protease (FSAP) expression in human monocytes and accumulation in unstable coronary atherosclerotic plaques. Atherosclerosis, 196 (1), 164–171.
   PubMed Web of Science ®Google Scholar
• Parker, C.E. and Borchers, C.H., 2014. Mass spectrometry based biomarker discovery, verification, and validation – quality assurance and control of protein biomarker assays. Molecular oncology, 8 (4), 840–858.
   PubMed Web of Science ®Google Scholar
• Parker, K.A. and Tollefsen, D.M., 1985. The protease specificity of heparin cofactor II. Inhibition of thrombin generated during coagulation. Journal of biological chemistry, 260 (6), 3501–3505.
   PubMed Web of Science ®Google Scholar
• Paulovich, A.G., et al., 2008. The interface between biomarker discovery and clinical validation: the tar pit of the protein biomarker pipeline. Proteomics - clinical applications, 2 (10–11), 1386–1402.
   PubMed Web of Science ®Google Scholar
• Penn, A.M., et al., 2015. Exploring phlebotomy technique as a pre-analytical factor in proteomic analyses by mass spectrometry. Genome, 58 (12), 569–576.
   PubMed Web of Science ®Google Scholar
• Pepe, M.S., et al., 2008. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. Journal of the National Cancer Institute, 100 (20), 1432–1438.
   PubMed Web of Science ®Google Scholar
• Pera, J., et al., 2013. Temporal changes of adiponectin plasma levels in patients with acute ischemic stroke. Neurological research, 35 (9), 988–991.
   PubMed Web of Science ®Google Scholar
• Perry, J.J., et al., 2017. Validation of the Ottawa Subarachnoid Hemorrhage Rule in patients with acute headache. Canadian Medical Association journal, 189 (45), E1379–E1385.
   Web of Science ®Google Scholar
• Perry, J.J., et al., 2011. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage: prospective cohort study. BMJ, 343 (1), d4277–d4277.
   PubMedGoogle Scholar
• Pike, R.N., et al., 2005. Control of the coagulation system by serpins. FEBS journal, 272 (19), 4842–4851.
   PubMed Web of Science ®Google Scholar
• Pinheiro, J., et al., 2016. nlme: Linear and nonlinear mixed effects models. Available from: https://CRAN.R-project.org/package=nlme.
   Google Scholar
• Plate, K.H., et al., 1999. Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct. Journal of neuropathology & experimental neurology, 58 (6), 654–666.
   PubMed Web of Science ®Google Scholar
• Popp, R., et al., 2017. Immuno-MALDI (iMALDI) for quantifying AKT1 and AKT2 in breast and colorectal cancer cell lines and tumors. Analytical chemistry, 89 (19), 10592–10600.
   PubMed Web of Science ®Google Scholar
• Prabhakaran, S., et al., 2008. Misdiagnosis of transient ischemic attacks in the emergency room. Cerebrovascular diseases (Basel, Switzerland), 26 (6), 630–635.
   PubMed Web of Science ®Google Scholar
• Prugger, C., et al., 2012. Adipocytokines and the risk of ischemic stroke: the PRIME study. Annals of neurology, 71 (4), 478–486.
   PubMed Web of Science ®Google Scholar
• Qizilbash, N., et al., 1997. Von Willebrand factor and risk of ischemic stroke. Neurology, 49 (6), 1552–1556.
   PubMed Web of Science ®Google Scholar
• Quinn, T.J., et al., 2009. ABCD2 scores and prediction of noncerebrovascular diagnoses in an outpatient population: a case-control study. Stroke, 40 (3), 749–753.
   PubMed Web of Science ®Google Scholar
• R Core Team. 2016. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. Available from: https://www.R-project.org.
   Google Scholar
• Rathore, S.S., et al., 2002. Characterization of incident stroke signs and symptoms: findings from the Atherosclerosis Risk in Communities Study. Stroke, 33 (11), 2718–2721.
   PubMed Web of Science ®Google Scholar
• Rau, J.C., et al., 2007. Serpins in thrombosis, hemostasis and fibrinolysis. Journal of thrombosis and haemostasis, 5(Suppl.1), 102–115.
   PubMed Web of Science ®Google Scholar
• Reddy, S.T., et al., 2001. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arteriosclerosis, thrombosis, and vascular biology, 21 (4), 542–547.
   PubMed Web of Science ®Google Scholar
• Redondo, M., et al., 1999. Coagulation factors II, V, VII, and X, prothrombin gene 20210G→A transition, and factor V leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction. Arteriosclerosis, thrombosis, and vascular biology, 19 (4), 1020–1025.
   PubMed Web of Science ®Google Scholar
• Robin, X., et al., 2011. pROC: an open-source package for R and S + to analyze and compare ROC curves. BMC bioinformatics, 12 (1), 77.
   PubMed Web of Science ®Google Scholar
• Rodriguez, H., et al., 2010. Reconstructing the pipeline by introducing multiplexed multiple reaction monitoring mass spectrometry for cancer biomarker verification: an NCI-CPTC initiative perspective. Proteomics – clinical applications, 4 (12), 904–914.
   PubMed Web of Science ®Google Scholar
• Savoia, C. and Schiffrin, E.L., 2007. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clinical science, 112 (7), 375–384.
   PubMed Web of Science ®Google Scholar
• Schwab, S., et al., 1997. Plasma insulin-like growth factor I and IGF binding protein 3 levels in patients with acute cerebral ischemic injury. Stroke, 28 (9), 1744–1748.
   PubMed Web of Science ®Google Scholar
• Sedlaczek, O., et al., 2004. Detection of delayed focal MR changes in the lateral hippocampus in transient global amnesia. Neurology, 62 (12), 2165–2170.
   PubMed Web of Science ®Google Scholar
• Sharma, R., et al., 2014. A blood-based biomarker panel to detect acute stroke. Journal of stroke and cerebrovascular diseases, 23 (5), 910–918.
   PubMed Web of Science ®Google Scholar
• Sheehan, O.C., et al., 2009. Diagnostic usefulness of the ABCD2 score to distinguish transient ischemic attack and minor ischemic stroke from noncerebrovascular events. Stroke, 40 (11), 3449–3454.
   PubMed Web of Science ®Google Scholar
• Shih, D.M., et al., 2007. Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice. Circulation research, 100 (8), 1200–1207.
   PubMed Web of Science ®Google Scholar
• Shimano, M., et al., 2008. Circulating adiponectin levels in patients with atrial fibrillation. Circulation journal, 72 (7), 1120–1124.
   PubMed Web of Science ®Google Scholar
• Sing, T., et al., 2005. ROCR: visualizing classifier performance in R. Bioinformatics (Oxford, England), 21 (20), 3940–3941.
   PubMed Web of Science ®Google Scholar
• Spectrometry in TIA Rapid Assessment [SpecTRA], 2016. Available from: http://www.viha.ca/rnd/current/spectra.htm.
   Google Scholar
• Suzuki, K., 2008. The multi-functional serpin, protein C inhibitor: beyond thrombosis and hemostasis. Journal of thrombosis and haemostasis, 6 (12), 2017–2026.
   PubMed Web of Science ®Google Scholar
• Toulon, P.A., et al., 2008. Heparin cofactor II (HCII) levels and the risk of ischemic stroke. No deleterious role of HCII deficiency but potential protective role of high plasma level. Blood, 112 (11), 5344.
   Google Scholar
• Trompet, S., et al., 2011. Factor VII activating protease polymorphism (G534E) is associated with increased risk for stroke and mortality. Stroke research and treatment, 2011, 424759.
   PubMedGoogle Scholar
• Vittinghoff, E. and McCulloch, C.E., 2007. Relaxing the rule of ten events per variable in logistic and Cox regression. American Journal of Epidemiology, 165 (6), 710–718.
   PubMed Web of Science ®Google Scholar
• Wang, S., et al., 2011. Random lasso. The annals of applied statistics, 5 (1), 468–485.
   PubMed Web of Science ®Google Scholar
• Whiteaker, J.R., et al., 2007. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer. Journal of proteome research, 6 (10), 3962–3975.
   PubMed Web of Science ®Google Scholar
• Whiteley, W., 2011. Identifying blood biomarkers to improve the diagnosis of stroke. The journal of the Royal College of Physicians of Edinburgh, 41, 152–154.
   PubMedGoogle Scholar
• Whiteley, W., et al., 2009. Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke, 40 (5), e380–e389.
   PubMed Web of Science ®Google Scholar
• Whiteley, W., Tseng, M.-C., and Sandercock, P., 2008. Blood biomarkers in the diagnosis of ischemic stroke: a systematic review. Stroke, 39, 2902–2909.
   PubMed Web of Science ®Google Scholar
• Whiteley, W., et al., 2011. Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study. Cerebrovascular diseases, 32, 141–147.
   PubMed Web of Science ®Google Scholar
• Wickham, H., 2009. ggplot2: elegant graphics for data analysis. New York, NY: Springer-Verlag.
   Google Scholar
• Wieberdink, R.G., et al., 2010. High von Willebrand factor levels increase the risk of stroke: the Rotterdam study. Stroke, 41 (10), 2151–2156.
   PubMed Web of Science ®Google Scholar
• Willeit, J., et al., 2003. Marburg I polymorphism of factor VII–activating protease: a prominent risk predictor of carotid stenosis. Circulation, 107 (5), 667–670.
   PubMed Web of Science ®Google Scholar
• Wolf, P.A., Abbott, R.D., and Kannel, W.B., 1991. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke, 22 (8), 983–988.
   PubMed Web of Science ®Google Scholar
• Wunderlich, M.T., Wallesch, C.-W., and Goertler, M., 2004. Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke. Journal of neurological sciences, 227 (1), 49–53.
   PubMed Web of Science ®Google Scholar
• Zhang, Z. and Chopp, M., 2002. Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia. Trends in cardiovascular medicine, 12 (2), 62–66.
   PubMed Web of Science ®Google Scholar